The board of Park Medi World at its meeting held on 05 January 2026 has approved the acquisition of whole of existing shareholding of Krishna Super-speciality Hospital which owns and operates Mahip Hospitals for a consideration of Rs 40 crore. Strategically positioned in the heart of Bathinda, Krishna Super-speciality Hospital serves as a vital healthcare hub for both urban and rural districts, offering a centralized location for multiple super-specialties. Park Medi World has been managing operations of Krishna Super-speciality Hospital since July 2025, and has now acquired 100% shareholding from the current promoters. With the addition of this hospital, Park Group increases its hospital capacity and strengthens its infrastructure, supporting its plan to reach a total of 5,260 beds by March 2028.Powered by Capital Market - Live News

The board of Park Medi World at its meeting held on 19 December 2025 has approved the acquisition of 100% stake in KP Institute of Medical Sciences (KPIMS), Agra, Uttar Pradesh, in an all-cash transaction amounting Rs 245 crore. Since its launch in 2023, KPIMS has become a prominent multi-specialty provider for Agra and neighbouring areas being one of the biggest healthcare facilities in the region. Upon consummation of the acquisition, KPIMS will be a 360 beded multi super speciality hospital. Its NABH accreditation, comprehensive super-specialty services, and inclusion in major insurance and government schemes, position KPIMS strongly for sustained market growth. Powered by Capital Market - Live News

The equity shares of Park Medi World (Scrip Code: 544645) are listed effective 17 December 2025 and admitted to dealings on the Exchange in the list of ``B`` Group Securities. At 09:13 IST, the pre-open indicative price of the stock was at a discount of 4.32% to the issue price of 162.Powered by Capital Market - Live News